Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Khan Najat
Over the trailing 90 days, Khan Najat (Director at RECURSION PHARMACEUTICALS, INC.) sold $275K of stock in RXRX, per 2 SEC Form 4 transactions.
- Role
- Director
- Companies
- RXRX
- Window
- Trailing 90 days · 2 transactions · CIK 2020969
- Net activity
- −$275K ($0 bought · $275K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 2 | — | $275K | −$275K |
Transactions (2)
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Khan's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.